A new method for differentiating benign and malignant pleomorphic clustered calcifications in mammography

Area of Science:

• Radiology
• Breast Imaging
• Oncology

Background:

• Mammography is crucial for detecting breast cancer.
• Pleomorphic calcifications require careful evaluation to differentiate benign from malignant lesions.
• Current imaging characteristics may not always be sufficient for definitive diagnosis.

Purpose of the Study:

• To evaluate a new mammographic characteristic, distribution area size (DAS), for improving the identification of benign versus malignant isolated clusters of coarse heterogeneous and fine pleomorphic calcifications.
• To determine if DAS can enhance diagnostic accuracy in differentiating suspicious calcifications.

Main Methods:

• Retrospective analysis of 123 women with pleomorphic clustered calcifications on mammography.
• Classification of calcifications based on density, heterogeneity, number, size heterogeneity, and distribution area size (DAS).
• Correlation of imaging findings, particularly DAS, with pathological biopsy results.

Main Results:

• Distribution area size (DAS) was the only significant differentiator between benign and malignant calcifications (p=0.009).
• A DAS of 32-55 mm² (OR=4.22) and ≥56 mm² (OR=5.55) were significantly associated with malignancy compared to <18 mm².
• The chi-square test confirmed the statistical significance of DAS in malignancy assessment.

Conclusions:

• Distribution area size (DAS) is a novel and reliable imaging metric for differentiating benign from malignant pleomorphic calcifications.
• Incorporating DAS into mammographic analysis can improve diagnostic accuracy.
• DAS provides valuable information for guiding decisions on whether to proceed with breast biopsies.